On the public citation graph

NMR-Based Approaches for the Identification and Optimization of Inhibitors of Protein–Protein Interactions

0 signed · 266 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/(sici)1521-3773(19990614)38:12<1784::aid-anie1784>3.0.co;2-qopenalex-snapshot
Characterization of Ligand Binding by Saturation Transfer Difference NMR Spectroscopy
inferredcites →https://doi.org/10.1002/1439-7633(20020301)3:2/3<167::aid-cbic167>3.0.co;2-sopenalex-snapshot
Spin Labels as a Tool to Identify and Characterize Protein-Ligand Interactions by NMR Spectroscopy
inferredcites →https://doi.org/10.1002/3527608761openalex-snapshot
Fragment‐based Approaches in Drug Discovery
inferredcites →https://doi.org/10.1002/9783527621286openalex-snapshot
Molecular Drug Properties
inferredcites →https://doi.org/10.1002/anie.200300595openalex-snapshot
NMR Studies of Structure and Function of Biological Macromolecules (Nobel Lecture)
inferredcites →https://doi.org/10.1002/anie.200353453openalex-snapshot
Paramagnetic Metal Ions in Ligand Screening: The CoII Matrix Metalloproteinase 12
inferredcites →https://doi.org/10.1002/anie.201201358openalex-snapshot
Discovery of Small Molecules that Bind to K‐Ras and Inhibit Sos‐Mediated Activation
inferredcites →https://doi.org/10.1002/anie.201206231openalex-snapshot
Small‐Molecule Inhibitors of the Interaction between the E3 Ligase VHL and HIF1α
inferredcites →https://doi.org/10.1002/bip.360370306openalex-snapshot
A review of the utility of soluble peptide combinatorial libraries
inferredcites →https://doi.org/10.1002/cbic.200400188openalex-snapshot
The Discovery of Novel Protein Kinase Inhibitors by Using Fragment‐Based High‐Throughput X‐ray Crystallography
inferredcites →https://doi.org/10.1002/chem.200500636openalex-snapshot
SAR by ILOEs: An NMR‐Based Approach to Reverse Chemical Genetics
inferredcites →https://doi.org/10.1002/mrc.1381openalex-snapshot
Competition STD NMR for the detection of high‐affinity ligands and NMR‐based screening
inferredcites →https://doi.org/10.1006/jmbi.1996.0603openalex-snapshot
Selective Methyl Group Protonation of Perdeuterated Proteins
inferredcites →https://doi.org/10.1007/128_2011_180openalex-snapshot
Introduction to Fragment-Based Drug Discovery
inferredcites →https://doi.org/10.1007/128_2011_183openalex-snapshot
Combining NMR and X-ray Crystallography in Fragment-Based Drug Discovery: Discovery of Highly Potent and Selective BACE-1 Inhibitors
inferredcites →https://doi.org/10.1007/128_2011_225openalex-snapshot
Combining Biophysical Screening and X-Ray Crystallography for Fragment-Based Drug Discovery
inferredcites →https://doi.org/10.1007/128_2011_265openalex-snapshot
Targeting Protein–Protein Interactions and Fragment-Based Drug Discovery
inferredcites →https://doi.org/10.1007/978-1-62703-398-5_6openalex-snapshot
Protein–Ligand Interactions Using SPR Systems
inferredcites →https://doi.org/10.1007/s00018-003-3382-3openalex-snapshot
Protein NMR in biomedical research
inferredcites →https://doi.org/10.1007/s10858-005-4425-xopenalex-snapshot
SOFAST-HMQC Experiments for Recording Two-dimensional Deteronuclear Correlation Spectra of Proteins within a Few Seconds
inferredcites →https://doi.org/10.1007/s10858-008-9277-8openalex-snapshot
Solution NMR structure determination of proteins revisited
inferredcites →https://doi.org/10.1007/s10858-010-9419-7openalex-snapshot
Optimal methyl labeling for studies of supra-molecular systems
inferredcites →https://doi.org/10.1007/s10858-013-9740-zopenalex-snapshot
Fragment-based drug discovery using NMR spectroscopy
inferredcites →https://doi.org/10.1016/0006-291x(80)90695-6openalex-snapshot
A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules
inferredcites →https://doi.org/10.1016/0006-2952(90)90185-nopenalex-snapshot
Determination of ligand conformation in macromolecular complexes using the transferred nuclear overhauser effect
inferredcites →https://doi.org/10.1016/0024-3205(93)90113-hopenalex-snapshot
The use of positional scanning synthetic peptide combinatorial libraries for the rapid determination of opioid receptor ligands
inferredcites →https://doi.org/10.1016/0165-6147(91)90535-zopenalex-snapshot
Comprehensive medicinal chemistry
inferredcites →https://doi.org/10.1016/0263-7855(94)80074-xopenalex-snapshot
Texture mapping: A new tool for molecular graphics
inferredcites →https://doi.org/10.1016/0263-7855(94)80094-4openalex-snapshot
Perspectives in medicinal chemistry
inferredcites →https://doi.org/10.1016/0958-1669(93)90003-fopenalex-snapshot
Determination of the conformations of bound peptides using NMR-transferred nOe techniques
inferredcites →https://doi.org/10.1016/0968-0896(96)00147-2openalex-snapshot
A new class of HIV-1 protease inhibitor: The crystallographic structure, inhibition and chemical synthesis of an aminimide peptide isostere
inferredcites →https://doi.org/10.1016/b978-0-12-381274-2.00008-xopenalex-snapshot
From Experimental Design to Validated Hits
inferredcites →https://doi.org/10.1016/j.bmc.2006.07.050openalex-snapshot
Discovery of novel inhibitors of the ZipA/FtsZ complex by NMR fragment screening coupled with structure-based design
inferredcites →https://doi.org/10.1016/j.bmcl.2004.11.010openalex-snapshot
Non-peptidic small molecule inhibitors of XIAP
inferredcites →https://doi.org/10.1016/j.bmcl.2013.04.096openalex-snapshot
Design, synthesis and evaluation of inhibitor of apoptosis protein (IAP) antagonists that are highly selective for the BIR2 domain of XIAP
inferredcites →https://doi.org/10.1016/j.cbpa.2004.04.003openalex-snapshot
Pursuing the leadlikeness concept in pharmaceutical research
inferredcites →https://doi.org/10.1016/j.cbpa.2005.05.002openalex-snapshot
Fragonomics: fragment-based drug discovery
inferredcites →https://doi.org/10.1016/j.cbpa.2006.04.006openalex-snapshot
Biomolecular NMR: a chaperone to drug discovery
inferredcites →https://doi.org/10.1016/j.cbpa.2007.07.010openalex-snapshot
Fragment-based screening using X-ray crystallography and NMR spectroscopy
inferredcites →https://doi.org/10.1016/j.cbpa.2008.08.019openalex-snapshot
Contemporary strategies for the stabilization of peptides in the α-helical conformation
inferredcites →https://doi.org/10.1016/j.chembiol.2004.05.022openalex-snapshot
Targeting Apoptosis via Chemical Design
inferredcites →https://doi.org/10.1016/j.chembiol.2004.12.004openalex-snapshot
TINS, Target Immobilized NMR Screening: An Efficient and Sensitive Method for Ligand Discovery
inferredcites →https://doi.org/10.1016/j.chembiol.2005.08.013openalex-snapshot
Solution Nuclear Magnetic Resonance Spectroscopy Techniques for Probing Intermolecular Interactions
inferredcites →https://doi.org/10.1016/j.chembiol.2012.10.015openalex-snapshot
HTS by NMR of Combinatorial Libraries: A Fragment-Based Approach to Ligand Discovery
inferredcites →https://doi.org/10.1016/j.sbi.2006.01.006openalex-snapshot
NMR studies of protein interactions
inferredcites →https://doi.org/10.1016/j.sbi.2010.09.001openalex-snapshot
Higher throughput calorimetry: opportunities, approaches and challenges
inferredcites →https://doi.org/10.1016/s0021-9258(18)45665-7openalex-snapshot
Protein structure determination in solution by NMR spectroscopy.
inferredcites →https://doi.org/10.1016/s0021-9258(18)82261-xopenalex-snapshot
Structure of a non-peptide inhibitor complexed with HIV-1 protease. Developing a cycle of structure-based drug design
inferredcites →https://doi.org/10.1016/s0076-6879(05)94023-8openalex-snapshot
Utilization of NMR-Derived Fragment Leads in Drug Design
inferredcites →https://doi.org/10.1016/s0079-6565(02)00049-3openalex-snapshot
NMR screening techniques in drug discovery and drug design
inferredcites →https://doi.org/10.1016/s0169-409x(00)00129-0openalex-snapshot
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1
inferredcites →https://doi.org/10.1016/s0959-440x(99)00011-1openalex-snapshot
NMR spectroscopy of large molecules and multimolecular assemblies in solution
inferredcites →https://doi.org/10.1016/s1359-6446(02)02556-4openalex-snapshot
Chris Lipinski discusses life and chemistry after the Rule of Five
inferredcites →https://doi.org/10.1016/s1359-6446(03)02796-xopenalex-snapshot
NMR-based screening technologies
inferredcites →https://doi.org/10.1016/s1359-6446(03)02831-9openalex-snapshot
A ‘Rule of Three’ for fragment-based lead discovery?
inferredcites →https://doi.org/10.1016/s1359644602025722openalex-snapshot
Nonleadlikeness and leadlikeness in biochemical screening
inferredcites →https://doi.org/10.1021/bi00011a032openalex-snapshot
Design, Synthesis, and Characterization of a Potent Xylose Isomerase Inhibitor, D-Threonohydroxamic Acid, and High-Resolution X-ray Crystallographic Structure of the Enzyme-Inhibitor Complex
inferredcites →https://doi.org/10.1021/bi00402a035openalex-snapshot
Analysis of an enzyme-substrate complex by x-ray crystallography and transferred nuclear overhauser enhancement measurements: porcine pancreatic elastase and a hexapeptide
inferredcites →https://doi.org/10.1021/cb700025jopenalex-snapshot
A Fragment-Based Approach for the Discovery of Isoform-Specific p38α Inhibitors
inferredcites →https://doi.org/10.1021/cc7001205openalex-snapshot
Strategies for the Use of Mixture-Based Synthetic Combinatorial Libraries: Scaffold Ranking, Direct Testing In Vivo, and Enhanced Deconvolution by Computational Methods
inferredcites →https://doi.org/10.1021/ci900132ropenalex-snapshot
Fragment-Based Computation of Binding Free Energies by Systematic Sampling
inferredcites →https://doi.org/10.1021/ja001241+openalex-snapshot
Second-Site NMR Screening with a Spin-Labeled First Ligand
inferredcites →https://doi.org/10.1021/ja005836gopenalex-snapshot
Spin Label Enhanced NMR Screening
inferredcites →https://doi.org/10.1021/ja0100120openalex-snapshot
Group Epitope Mapping by Saturation Transfer Difference NMR To Identify Segments of a Ligand in Direct Contact with a Protein Receptor
inferredcites →https://doi.org/10.1021/ja020174bopenalex-snapshot
High-Throughput NMR-Based Screening with Competition Binding Experiments
inferredcites →https://doi.org/10.1021/ja029221qopenalex-snapshot
Use of Selective Trp Side Chain Labeling To Characterize Protein−Protein and Protein−Ligand Interactions by NMR Spectroscopy
inferredcites →https://doi.org/10.1021/ja066915gopenalex-snapshot
UltraSOFAST HMQC NMR and the Repetitive Acquisition of 2D Protein Spectra at Hz Rates
inferredcites →https://doi.org/10.1021/ja074725fopenalex-snapshot
Design, Synthesis, and Characterization of a Potent, Nonpeptide, Cell-Permeable, Bivalent Smac Mimetic That Concurrently Targets Both the BIR2 and BIR3 Domains in XIAP
inferredcites →https://doi.org/10.1021/ja209924vopenalex-snapshot
Targeting the von Hippel–Lindau E3 Ubiquitin Ligase Using Small Molecules To Disrupt the VHL/HIF-1α Interaction
inferredcites →https://doi.org/10.1021/ja9702778openalex-snapshot
Discovery of Potent Nonpeptide Inhibitors of Stromelysin Using SAR by NMR
inferredcites →https://doi.org/10.1021/ja9715962openalex-snapshot
One-Dimensional Relaxation- and Diffusion-Edited NMR Methods for Screening Compounds That Bind to Macromolecules
inferredcites →https://doi.org/10.1021/jm010927popenalex-snapshot
SAR and X-ray. A New Approach Combining Fragment-Based Screening and Rational Drug Design: Application to the Discovery of Nanomolar Inhibitors of Src SH2
inferredcites →https://doi.org/10.1021/jm011122kopenalex-snapshot
NMR-Based Screening with Competition Water−Ligand Observed via Gradient Spectroscopy Experiments: Detection of High-Affinity Ligands
inferredcites →https://doi.org/10.1021/jm030191ropenalex-snapshot
Identification and Prediction of Promiscuous Aggregating Inhibitors among Known Drugs
inferredcites →https://doi.org/10.1021/jm030266ropenalex-snapshot
A Specific Mechanism of Nonspecific Inhibition
inferredcites →https://doi.org/10.1021/jm040031vopenalex-snapshot
Fragment-Based Drug Discovery
inferredcites →https://doi.org/10.1021/jm040037kopenalex-snapshot
Discovery of Potent Antagonists of the Antiapoptotic Protein XIAP for the Treatment of Cancer
inferredcites →https://doi.org/10.1021/jm0495778openalex-snapshot
Fragment-Based Lead Discovery Using X-ray Crystallography
inferredcites →https://doi.org/10.1021/jm049967uopenalex-snapshot
Integrating Fragment Assembly and Biophysical Methods in the Chemical Advancement of Small-Molecule Antagonists of IL-2: An Approach for Inhibiting Protein−Protein Interactions
inferredcites →https://doi.org/10.1021/jm0507532openalex-snapshot
Discovery of a Potent Inhibitor of the Antiapoptotic Protein Bcl-x L from NMR and Parallel Synthesis
inferredcites →https://doi.org/10.1021/jm060029zopenalex-snapshot
Synergy and Antagonism of Promiscuous Inhibition in Multiple-Compound Mixtures
inferredcites →https://doi.org/10.1021/jm061103gopenalex-snapshot
Interpreting Steep Dose-Response Curves in Early Inhibitor Discovery
inferredcites →https://doi.org/10.1021/jm061317yopenalex-snapshot
A High-Throughput Screen for Aggregation-Based Inhibition in a Large Compound Library
inferredcites →https://doi.org/10.1021/jm061481lopenalex-snapshot
Development of Molecular Probes for Second-Site Screening and Design of Protein Tyrosine Phosphatase Inhibitors
inferredcites →https://doi.org/10.1021/jm070365vopenalex-snapshot
An NMR-Based Antagonist Induced Dissociation Assay for Targeting the Ligand−Protein and Protein−Protein Interactions in Competition Binding Experiments
inferredcites →https://doi.org/10.1021/jm0707424openalex-snapshot
Nuclear Magnetic Resonance Fragment-Based Identification of Novel FKBP12 Inhibitors
inferredcites →https://doi.org/10.1021/jm100059dopenalex-snapshot
Fragment-Based Drug Discovery Applied to Hsp90. Discovery of Two Lead Series with High Ligand Efficiency
inferredcites →https://doi.org/10.1021/jm100060bopenalex-snapshot
Discovery of (2,4-Dihydroxy-5-isopropylphenyl)-[5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl]methanone (AT13387), a Novel Inhibitor of the Molecular Chaperone Hsp90 by Fragment Based Drug Design
inferredcites →https://doi.org/10.1021/jm100487zopenalex-snapshot
Nonpeptidic and Potent Small-Molecule Inhibitors of cIAP-1/2 and XIAP Proteins
inferredcites →https://doi.org/10.1021/jm200826sopenalex-snapshot
SAR by Interligand Nuclear Overhauser Effects (ILOEs) Based Discovery of Acylsulfonamide Compounds Active against Bcl-x L and Mcl-1
inferredcites →https://doi.org/10.1021/jm201072xopenalex-snapshot
Bivalent Smac Mimetics with a Diazabicyclic Core as Highly Potent Antagonists of XIAP and cIAP1/2 and Novel Anticancer Agents
inferredcites →https://doi.org/10.1021/jm300060kopenalex-snapshot
Discovery of a Potent Small-Molecule Antagonist of Inhibitor of Apoptosis (IAP) Proteins and Clinical Candidate for the Treatment of Cancer (GDC-0152)
inferredcites →https://doi.org/10.1021/jm301448popenalex-snapshot
Discovery of Potent Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based Methods and Structure-Based Design
inferredcites →https://doi.org/10.1021/jm301837nopenalex-snapshot
Antagonists of Protein–Protein Interactions Made Easy?
inferredcites →https://doi.org/10.1021/jm4002605openalex-snapshot
De Novo Fragment Design: A Medicinal Chemistry Approach to Fragment-Based Lead Generation
inferredcites →https://doi.org/10.1021/jm401333uopenalex-snapshot
Discovery of a Potent Inhibitor of Replication Protein A Protein–Protein Interactions Using a Fragment-Linking Approach
inferredcites →https://doi.org/10.1021/jm401582copenalex-snapshot
Targeting Low-Druggability Bromodomains: Fragment Based Screening and Inhibitor Design against the BAZ2B Bromodomain
inferredcites →https://doi.org/10.1021/jm800068wopenalex-snapshot
Development of Paramagnetic Probes for Molecular Recognition Studies in Protein Kinases
inferredcites →https://doi.org/10.1021/jm8006849openalex-snapshot
Structure-Based Design, Synthesis, Evaluation, and Crystallographic Studies of Conformationally Constrained Smac Mimetics as Inhibitors of the X-linked Inhibitor of Apoptosis Protein (XIAP)
inferredcites →https://doi.org/10.1021/jm8006992openalex-snapshot
Fragment-Based Design of Small Molecule X-Linked Inhibitor of Apoptosis Protein Inhibitors
inferredcites →https://doi.org/10.1021/jm801605ropenalex-snapshot
Promiscuous Aggregate-Based Inhibitors Promote Enzyme Unfolding
inferredcites →https://doi.org/10.1021/jm901137jopenalex-snapshot
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
inferredcites →https://doi.org/10.1021/jm901472uopenalex-snapshot
Application of Fragment-Based NMR Screening, X-ray Crystallography, Structure-Based Design, and Focused Chemical Library Design to Identify Novel μM Leads for the Development of nM BACE-1 (β-Site APP Cleaving Enzyme 1) Inhibitors
inferredcites →https://doi.org/10.1021/jm990174vopenalex-snapshot
Mixture-Based Synthetic Combinatorial Libraries
inferredcites →https://doi.org/10.1021/ml400032yopenalex-snapshot
Discovery of Protein–Protein Interaction Inhibitors of Replication Protein A
inferredcites →https://doi.org/10.1021/ml400296copenalex-snapshot
Is NMR Fragment Screening Fine-Tuned to Assess Druggability of Protein–Protein Interactions?
inferredcites →https://doi.org/10.1023/a:1008354229396openalex-snapshot
Identification of compounds with binding affinity to proteins via magnetization transfer from bulk water*
inferredcites →https://doi.org/10.1023/a:1008393201236openalex-snapshot
A robust and cost-effective method for the production of Val, Leu, Ile (δ1) methyl-protonated 15N-, 13C-, 2H-labeled proteins
inferredcites →https://doi.org/10.1023/a:1013302231549openalex-snapshot
WaterLOGSY as a method for primary NMR screening: Practical aspects and range of applicability
inferredcites →https://doi.org/10.1023/a:1014256707875openalex-snapshot
NMR-based structural characterization of large protein-ligand interactions
inferredcites →https://doi.org/10.1037/e496242006-015openalex-snapshot
Modified Solid-Phase Methods for the Rapid Synthesis of Opioid Peptides
inferredcites →https://doi.org/10.1038/35050012openalex-snapshot
Structural basis of IAP recognition by Smac/DIABLO
inferredcites →https://doi.org/10.1038/354084a0openalex-snapshot
Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery
inferredcites →https://doi.org/10.1038/728openalex-snapshot
The second decade — into the third millenium
inferredcites →https://doi.org/10.1038/nature03579openalex-snapshot
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
inferredcites →https://doi.org/10.1038/nature06526openalex-snapshot
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
inferredcites →https://doi.org/10.1038/nchem.1568openalex-snapshot
Inhibition of α-helix-mediated protein–protein interactions using designed molecules
inferredcites →https://doi.org/10.1038/nchembio.155openalex-snapshot
Molecular docking and ligand specificity in fragment-based inhibitor discovery
inferredcites →https://doi.org/10.1038/nchembio718openalex-snapshot
High-throughput assays for promiscuous inhibitors
inferredcites →https://doi.org/10.1038/nm.3048openalex-snapshot
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
inferredcites →https://doi.org/10.1038/nprot.2006.101openalex-snapshot
Isotope labeling strategies for the study of high-molecular-weight proteins by solution NMR spectroscopy
inferredcites →https://doi.org/10.1038/nprot.2006.77openalex-snapshot
A detergent-based assay for the detection of promiscuous inhibitors
inferredcites →https://doi.org/10.1038/nrd1343openalex-snapshot
Small-molecule inhibitors of protein–protein interactions: progressing towards the dream
inferredcites →https://doi.org/10.1038/nrd1467openalex-snapshot
Fragment-based lead discovery
inferredcites →https://doi.org/10.1038/nrd2220openalex-snapshot
A decade of fragment-based drug design: strategic advances and lessons learned
inferredcites →https://doi.org/10.1038/nrd2606openalex-snapshot
Perspectives on NMR in drug discovery: a technique comes of age
inferredcites →https://doi.org/10.1038/nrd748openalex-snapshot
Nmr in drug discovery
inferredcites →https://doi.org/10.1039/b210047aopenalex-snapshot
NMR-based methods and strategies for drug discovery
inferredcites →https://doi.org/10.1039/b605309mopenalex-snapshot
NMR-based screening: a powerful tool in fragment-based drug discovery
inferredcites →https://doi.org/10.1039/b616314aopenalex-snapshot
Stability and equilibria of promiscuous aggregates in high protein milieus
inferredcites →https://doi.org/10.1042/bj20100651openalex-snapshot
Fragment-based screening by X-ray crystallography, MS and isothermal titration calorimetry to identify PNMT (phenylethanolamine N-methyltransferase) inhibitors
inferredcites →https://doi.org/10.1073/pnas.0603460103openalex-snapshot
Structure–activity relationships by interligand NOE-based design and synthesis of antiapoptotic compounds targeting Bid
inferredcites →https://doi.org/10.1073/pnas.0701297104openalex-snapshot
Structural insights into the degradation of Mcl-1 induced by BH3 domains
inferredcites →https://doi.org/10.1073/pnas.252756299openalex-snapshot
Binding of small molecules to an adaptive protein–protein interface
inferredcites →https://doi.org/10.1073/pnas.94.23.12366openalex-snapshot
Attenuated T 2 relaxation by mutual cancellation of dipole–dipole coupling and chemical shift anisotropy indicates an avenue to NMR structures of very large biological macromolecules in solution
inferredcites →https://doi.org/10.1074/jbc.m109.064824openalex-snapshot
Structural Characterization of the EphA4-Ephrin-B2 Complex Reveals New Features Enabling Eph-Ephrin Binding Promiscuity
inferredcites →https://doi.org/10.1074/jbc.m413122200openalex-snapshot
Inhibition of Yersinia Tyrosine Phosphatase by Furanyl Salicylate Compounds
inferredcites →https://doi.org/10.1111/j.1747-0285.2008.00768.xopenalex-snapshot
Identification of Allosteric PIF‐Pocket Ligands for PDK1 using NMR‐Based Fragment Screening and 1H‐15N TROSY Experiments
inferredcites →https://doi.org/10.1111/j.1747-0285.2009.00795.xopenalex-snapshot
Discovery and Binding Studies on a Series of Novel Pin1 Ligands
inferredcites →https://doi.org/10.1111/j.1747-0285.2010.00982.xopenalex-snapshot
NMR‐Based Design and Evaluation of Novel Bidentate Inhibitors of the Protein Tyrosine Phosphatase YopH
inferredcites →https://doi.org/10.1124/mi.9.1.7openalex-snapshot
Fragment-based ligand discovery
inferredcites →https://doi.org/10.1126/science.274.5292.1531openalex-snapshot
Discovering High-Affinity Ligands for Proteins: SAR by NMR
inferredcites →https://doi.org/10.1126/science.8451640openalex-snapshot
Structure-Based Discovery of Inhibitors of Thymidylate Synthase
inferredcites →https://doi.org/10.1158/1535-7163.mct-13-0153openalex-snapshot
Small-Molecule IAP Antagonists Sensitize Cancer Cells to TRAIL-Induced Apoptosis: Roles of XIAP and cIAPs
inferredcites →https://doi.org/10.1158/1538-7445.am2013-2944openalex-snapshot
Abstract 2944: AT-IAP, a dual cIAP1 and XIAP antagonist with oral antitumor activity in melanoma models.
inferredcites →https://doi.org/10.1177/1087057110375614openalex-snapshot
Target Immobilization as a Strategy for NMR-Based Fragment Screening: Comparison of TINS, STD, and SPR for Fragment Hit Identification
inferredcites →https://doi.org/10.1177/1087057110389038openalex-snapshot
Experimental Validation of a Fragment Library for Lead Discovery Using SPR Biosensor Technology
inferredcites →https://doi.org/10.1177/1087057111407763openalex-snapshot
HTS Promiscuity Analyses for Accelerating Decision Making
inferredcites →https://doi.org/10.1177/1087057111430987openalex-snapshot
Fragment-Based Screening for Inhibitors of PDE4A Using Enthalpy Arrays and X-ray Crystallography
inferredcites →https://doi.org/10.1177/1087057113516861openalex-snapshot
Identification of Small-Molecule Frequent Hitters from AlphaScreen High-Throughput Screens
inferredcites →https://doi.org/10.1182/blood-2013-01-475855openalex-snapshot
ABT-199, a new Bcl-2–specific BH3 mimetic, has in vivo efficacy against aggressive Myc-driven mouse lymphomas without provoking thrombocytopenia
inferredcites →https://doi.org/10.1385/0-89603-392-9:13openalex-snapshot
Synthesis and Screening of Positional Scanning Combinatorial Libraries
inferredcites →https://doi.org/10.1385/1-59745-116-9:71openalex-snapshot
Non-Protein Amino Acids in the Design of Secondary Structure Scaffolds
inferredcites →https://doi.org/10.1517/14728222.8.6.597openalex-snapshot
NMR-based techniques in the hit identification and optimisation processes
inferredcites →https://doi.org/10.2174/138161206778743619openalex-snapshot
Protein NMR-Based Screening in Drug Discovery
inferredcites →https://doi.org/10.2174/1386207023329923openalex-snapshot
Fluorine-NMR Competition Binding Experiments for High-Throughput Screening of Large Compound Mixtures
inferredcites →https://doi.org/10.2174/1386207023329950openalex-snapshot
Applications of SHAPES Screening in Drug Discovery
inferredcites →https://doi.org/10.2174/1389557023405747openalex-snapshot
Mimetics of the Peptide β-Strand
inferredcites →https://doi.org/10.2174/156802609790102392openalex-snapshot
Fragment Library Screening and Lead Characterization Using SPR Biosensors
inferredcites →https://doi.org/10.2174/157016306778108884openalex-snapshot
The Nuclear Overhauser Effect in the Lead Identification Process Pharmacophore Models

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1002/9781118771723.ch8openalex-snapshot
Fragment‐Based Drug Discovery
inferred← citeshttps://doi.org/10.1002/adma.201703009openalex-snapshot
Direct Imaging of Superwetting Behavior on Solid–Liquid–Vapor Triphase Interfaces
inferred← citeshttps://doi.org/10.1002/advs.202410086openalex-snapshot
Expanding the Functions of KHSRP Protein: Insights into DNA G‐Quadruplex Binding
inferred← citeshttps://doi.org/10.1002/ange.201707682openalex-snapshot
Differential Epitope Mapping by STD NMR Spectroscopy To Reveal the Nature of Protein–Ligand Contacts
inferred← citeshttps://doi.org/10.1002/ange.201916257openalex-snapshot
Multicomponent Peptide Stapling as a Diversity‐Driven Tool for the Development of Inhibitors of Protein–Protein Interactions
inferred← citeshttps://doi.org/10.1002/anie.201707682openalex-snapshot
Differential Epitope Mapping by STD NMR Spectroscopy To Reveal the Nature of Protein–Ligand Contacts
inferred← citeshttps://doi.org/10.1002/anie.201916257openalex-snapshot
Multicomponent Peptide Stapling as a Diversity‐Driven Tool for the Development of Inhibitors of Protein–Protein Interactions
inferred← citeshttps://doi.org/10.1002/cbic.201500564openalex-snapshot
New p32/gC1qR Ligands for Targeted Tumor Drug Delivery
inferred← citeshttps://doi.org/10.1002/cbic.202300006openalex-snapshot
Nutlin‐3a‐aa: Improving the Bioactivity of a p53/MDM2 Interaction Inhibitor by Introducing a Solvent‐Exposed Methylene Group
inferred← citeshttps://doi.org/10.1002/chem.201600114openalex-snapshot
Unveiling the “Three‐Finger Pharmacophore” Required for p53–MDM2 Inhibition by Saturation‐Transfer Difference (STD) NMR Initial Growth‐Rates Approach
inferred← citeshttps://doi.org/10.1002/cmdc.201500441openalex-snapshot
High‐Throughput Screening (HTS) by NMR Guided Identification of Novel Agents Targeting the Protein Docking Domain of YopH
inferred← citeshttps://doi.org/10.1002/cmdc.201600039openalex-snapshot
The Cell Surface Receptor CD44: NMR‐Based Characterization of Putative Ligands
inferred← citeshttps://doi.org/10.1002/cmdc.201900574openalex-snapshot
Optimized Inhibitors of MDM2 via an Attempted Protein‐Templated Reductive Amination
inferred← citeshttps://doi.org/10.1002/cmdc.202000355openalex-snapshot
Stability and Cell Permeability of Sulfonyl Fluorides in the Design of Lys‐Covalent Antagonists of Protein‐Protein Interactions
inferred← citeshttps://doi.org/10.1002/med.21393openalex-snapshot
Medicinal Chemistry Strategies to Disrupt the p53–MDM2/MDMX Interaction
inferred← citeshttps://doi.org/10.1002/med.21585openalex-snapshot
Emerging roles of allosteric modulators in the regulation of protein‐protein interactions (PPIs): A new paradigm for PPI drug discovery
inferred← citeshttps://doi.org/10.1007/7355_2021_133openalex-snapshot
Protein Labeling and Structure Determination by NMR Spectroscopy
inferred← citeshttps://doi.org/10.1007/978-1-0716-4232-0_2openalex-snapshot
BACE-1 Inhibition for the Treatment of Neurodegenerative Diseases: Rationale, Assay Methodologies, and Reference Compounds
inferred← citeshttps://doi.org/10.1007/978-3-642-35943-9_303-1openalex-snapshot
Protein NMR: Introduction
inferred← citeshttps://doi.org/10.1007/978-981-13-0773-7_5openalex-snapshot
Experimental Methods Used for Identifying Small-Molecule Inhibitors of Protein-Protein Interaction
inferred← citeshttps://doi.org/10.1007/978-981-15-9235-5_10openalex-snapshot
Application of FMO to Ligand Design: SBDD, FBDD, and Protein–Protein Interaction
inferred← citeshttps://doi.org/10.1007/978-981-16-1594-8_2openalex-snapshot
Structural Aspects of Protein–Protein Interactions
inferred← citeshttps://doi.org/10.1007/s12551-018-0464-xopenalex-snapshot
The role of small-angle scattering in structure-based screening applications
inferred← citeshttps://doi.org/10.1016/b978-0-12-409547-2.12326-1openalex-snapshot
Small-Molecule Inhibitors of Protein–Protein Interactions
inferred← citeshttps://doi.org/10.1016/b978-0-12-409547-2.12330-3openalex-snapshot
Label-Free Screening Technologies
inferred← citeshttps://doi.org/10.1016/b978-0-443-16158-2.00003-3openalex-snapshot
Identification and purification of plant secondary metabolite as medicinal raw materials
inferred← citeshttps://doi.org/10.1016/bs.armc.2017.07.002openalex-snapshot
Fragment-Based Lead Discovery
inferred← citeshttps://doi.org/10.1016/bs.arnmr.2018.08.002openalex-snapshot
Applications of Hyperpolarisation and NMR Long-Lived States in Drug Screening
inferred← citeshttps://doi.org/10.1016/bs.mie.2018.09.022openalex-snapshot
Hit-to-Lead: Hit Validation and Assessment
inferred← citeshttps://doi.org/10.1016/j.bbapap.2026.141137openalex-snapshot
Localization and functional exploration of leiomodin-2's C-terminal binding sites
inferred← citeshttps://doi.org/10.1016/j.bmc.2022.116879openalex-snapshot
Fragment hopping protocol for the design of small-molecule protein–protein interaction inhibitors
inferred← citeshttps://doi.org/10.1016/j.bpj.2016.01.033openalex-snapshot
Cationic Peptides and Peptidomimetics Bind Glycosaminoglycans as Potential Sema3A Pathway Inhibitors
inferred← citeshttps://doi.org/10.1016/j.bpj.2026.03.033openalex-snapshot
Prediction accuracy of ligand binding kinetics
inferred← citeshttps://doi.org/10.1016/j.cbpa.2015.10.032openalex-snapshot
Advances in discovering small molecules to probe protein function in a systems context
inferred← citeshttps://doi.org/10.1016/j.chembiol.2015.06.011openalex-snapshot
Design and Characterization of Novel EphA2 Agonists for Targeted Delivery of Chemotherapy to Cancer Cells
inferred← citeshttps://doi.org/10.1016/j.chembiol.2017.01.006openalex-snapshot
Potent and Selective EphA4 Agonists for the Treatment of ALS
inferred← citeshttps://doi.org/10.1016/j.drudis.2020.07.012openalex-snapshot
Noncellular screening for the discovery of protein–protein interaction modulators
inferred← citeshttps://doi.org/10.1016/j.ejmech.2016.11.029openalex-snapshot
Rational design and synthesis of 1,5-disubstituted tetrazoles as potent inhibitors of the MDM2-p53 interaction
inferred← citeshttps://doi.org/10.1016/j.ejmech.2018.03.009openalex-snapshot
Identification of small-molecule inhibitors of USP2a
inferred← citeshttps://doi.org/10.1016/j.ejmech.2019.111588openalex-snapshot
Hitting on the move: Targeting intrinsically disordered protein states of the MDM2-p53 interaction
inferred← citeshttps://doi.org/10.1016/j.ejmech.2020.112376openalex-snapshot
Recent advance on PTP1B inhibitors and their biomedical applications
inferred← citeshttps://doi.org/10.1016/j.ejmech.2023.115500openalex-snapshot
Small molecule-mediated targeting of microRNAs for drug discovery: Experiments, computational techniques, and disease implications
inferred← citeshttps://doi.org/10.1016/j.ejmech.2025.118388openalex-snapshot
Exploring advanced methodologies for NS5 methyltransferase targeted drug discovery
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2019.12.171openalex-snapshot
NMR-based investigation into protein phosphorylation
inferred← citeshttps://doi.org/10.1016/j.jmb.2020.02.029openalex-snapshot
Unraveling Allostery in a Knotted Minimal Methyltransferase by NMR Spectroscopy
inferred← citeshttps://doi.org/10.1016/j.jmgm.2017.02.013openalex-snapshot
Application of the fragment molecular orbital method analysis to fragment-based drug discovery of BET (bromodomain and extra-terminal proteins) inhibitors
inferred← citeshttps://doi.org/10.1016/j.jpba.2019.112899openalex-snapshot
Advanced analytical methodologies in Alzheimer’s disease drug discovery
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2022.108110openalex-snapshot
Early-stage structure-based drug discovery for small GTPases by NMR spectroscopy
inferred← citeshttps://doi.org/10.1016/j.tips.2016.05.008openalex-snapshot
Systematic Targeting of Protein–Protein Interactions
inferred← citeshttps://doi.org/10.1021/acs.analchem.1c00601openalex-snapshot
How to Develop and Prove High-Efficiency Selection of Ligands from Oligonucleotide Libraries: A Universal Framework for Aptamers and DNA-Encoded Small-Molecule Ligands
inferred← citeshttps://doi.org/10.1021/acs.analchem.5c01494openalex-snapshot
Cell Permeability and Target Engagement of Middle-Sized Molecules Quantified by In-Cell NMR
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.0c01285openalex-snapshot
Therapeutic Targeting of MMP-12 for the Treatment of Chronic Obstructive Pulmonary Disease
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.1c00005openalex-snapshot
Design, Synthesis, and Structural Characterization of Lysine Covalent BH3 Peptides Targeting Mcl-1
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.1c00608openalex-snapshot
NMR-Guided Design of Potent and Selective EphA4 Agonistic Ligands
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.3c00467openalex-snapshot
Characterization of a Potent and Orally Bioavailable Lys-Covalent Inhibitor of Apoptosis Protein (IAP) Antagonist
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.3c01073openalex-snapshot
Mixture-Based Screening of Focused Combinatorial Libraries by NMR: Application to the Antiapoptotic Protein hMcl-1
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.3c02222openalex-snapshot
A Novel NMR-Based Protocol to Screen Ultralow Molecular Weight Fragments
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.4c00277openalex-snapshot
Histidine-Covalent Stapled Alpha-Helical Peptides Targeting hMcl-1
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.4c01541openalex-snapshot
Covalent Targeting of Histidine Residues with Aryl Fluorosulfates: Application to Mcl-1 BH3 Mimetics
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.4c03115openalex-snapshot
Target Engagement Assays in Early Drug Discovery
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5b01114openalex-snapshot
Ligand-Orientation Based Fragment Selection in STD NMR Screening
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.9b00561openalex-snapshot
Covalent Inhibitors of Protein–Protein Interactions Targeting Lysine, Tyrosine, or Histidine Residues
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.9b01108openalex-snapshot
Aryl-fluorosulfate-based Lysine Covalent Pan-Inhibitors of Apoptosis Protein (IAP) Antagonists with Cellular Efficacy
inferred← citeshttps://doi.org/10.1021/acs.jpcb.5c05704openalex-snapshot
The Butterfly Structure of Leucomethylene Blue Results in Weak Binding to Single- or Double-Stranded DNA
inferred← citeshttps://doi.org/10.1021/acs.langmuir.5c05185openalex-snapshot
Photocontrolled Liquid Crystal Droplets and Solution Tuning for Sub-nanomolar Protein Detection
inferred← citeshttps://doi.org/10.1021/acsaem.6c01616openalex-snapshot
Pb−S Anchored CsPbBr3 Nanorods with Preserved 1D Morphology and Enhanced Stability in Water for Visible-Light Photocatalysis
inferred← citeshttps://doi.org/10.1021/acscatal.5c07877openalex-snapshot
A Convergent, One-Step Biocatalytic Cascade for the Synthesis of Structurally Diverse Noncanonical Amino Acids
inferred← citeshttps://doi.org/10.1021/acschembio.2c00583openalex-snapshot
Exploring the Surface of the Ectodomain of the PD-L1 Immune Checkpoint with Small-Molecule Fragments
inferred← citeshttps://doi.org/10.1021/acschembio.6b00596openalex-snapshot
A Unique Mdm2-Binding Mode of the 3-Pyrrolin-2-one- and 2-Furanone-Based Antagonists of the p53-Mdm2 Interaction
inferred← citeshttps://doi.org/10.1021/acschembio.6b00730openalex-snapshot
Protein-Observed Fluorine NMR Is a Complementary Ligand Discovery Method to 1H CPMG Ligand-Observed NMR
inferred← citeshttps://doi.org/10.1021/acschembio.7b00717openalex-snapshot
Enthalpy-Based Screening of Focused Combinatorial Libraries for the Identification of Potent and Selective Ligands
inferred← citeshttps://doi.org/10.1021/acsmedchemlett.4c00540openalex-snapshot
Beyond Isotopic Labeling: Expanding the Reach of Protein-Detect NMR in Lead Discovery
inferred← citeshttps://doi.org/10.1021/acsmedchemlett.7b00483openalex-snapshot
HTS by NMR for the Identification of Potent and Selective Inhibitors of Metalloenzymes
inferred← citeshttps://doi.org/10.1021/cb500249jopenalex-snapshot
Versatile Cardiac Troponin Chimera for Muscle Protein Structural Biology and Drug Discovery
inferred← citeshttps://doi.org/10.1021/jacs.4c04000openalex-snapshot
Rapid Protein–Ligand Affinity Determination by Photoinduced Hyperpolarized NMR
inferred← citeshttps://doi.org/10.1021/jacs.6b00328openalex-snapshot
Finding the Right Candidate for the Right Position: A Fast NMR-Assisted Combinatorial Method for Optimizing Nucleic Acids Binders
inferred← citeshttps://doi.org/10.1021/jacs.6b00416openalex-snapshot
Sensitive NMR Approach for Determining the Binding Mode of Tightly Binding Ligand Molecules to Protein Targets
inferred← citeshttps://doi.org/10.1021/jp5099156openalex-snapshot
Ligand Characterization of Covalently Functionalized Mesoporous Silica Nanoparticles: An NMR Toolbox Approach
inferred← citeshttps://doi.org/10.1038/s41598-019-48826-6openalex-snapshot
Comprehensive in vitro characterization of PD-L1 small molecule inhibitors
inferred← citeshttps://doi.org/10.1038/s41598-021-95424-6openalex-snapshot
Bioactive recombinant human oncostatin M for NMR-based screening in drug discovery
inferred← citeshttps://doi.org/10.1038/s42004-022-00755-8openalex-snapshot
Binding-driven reactivity attenuation enables NMR identification of selective drug candidates for nucleic acid targets
inferred← citeshttps://doi.org/10.1039/9781788010016-00044openalex-snapshot
Receptor-based NMR Techniques in Drug Discovery
inferred← citeshttps://doi.org/10.1039/9781788016544-00049openalex-snapshot
High Throughput Screening Methods for PPI Inhibitor Discovery
inferred← citeshttps://doi.org/10.1039/c5cs00252dopenalex-snapshot
State-of-the-art strategies for targeting protein–protein interactions by small-molecule inhibitors
inferred← citeshttps://doi.org/10.1039/c7md00058hopenalex-snapshot
Scaffold hopping via ANCHOR.QUERY: β-lactams as potent p53-MDM2 antagonists
inferred← citeshttps://doi.org/10.1039/d0cc02988bopenalex-snapshot
Detecting protein–protein interactions by Xe-129 NMR
inferred← citeshttps://doi.org/10.1073/pnas.1616100114openalex-snapshot
Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/Syntenin
inferred← citeshttps://doi.org/10.1080/17460441.2017.1280456openalex-snapshot
Screening-based approaches to identify small molecules that inhibit protein–protein interactions
inferred← citeshttps://doi.org/10.1093/jxb/eraa440openalex-snapshot
Nitric oxide and hydrogen sulfide modulate the NADPH-generating enzymatic system in higher plants
inferred← citeshttps://doi.org/10.1109/iceect61758.2024.10739146openalex-snapshot
A Comparative Analysis of GCN and GAT for Predicting Protein-Protein Interactions
inferred← citeshttps://doi.org/10.1111/febs.14774openalex-snapshot
A fluorinated indole‐based MDM 2 antagonist selectively inhibits the growth of p53wt osteosarcoma cells
inferred← citeshttps://doi.org/10.1155/2019/2796746openalex-snapshot
3-Mercaptopropionic, 4-Mercaptobenzoic, and Oleic Acid-Capped CdSe Quantum Dots: Interparticle Distance, Anchoring Groups, and Surface Passivation
inferred← citeshttps://doi.org/10.18632/oncotarget.8719openalex-snapshot
Necrosis-inducing peptide has the beneficial effect on killing tumor cells through neuropilin (NRP-1) targeting
inferred← citeshttps://doi.org/10.2174/1568026615666150519102459openalex-snapshot
High-Throughput Screening by Nuclear Magnetic Resonance (HTS by NMR) for the Identification of PPIs Antagonists
inferred← citeshttps://doi.org/10.3390/ijms19092470openalex-snapshot
Specific Antibody Fragment Ligand Traps Blocking FGF1 Activity
inferred← citeshttps://doi.org/10.3390/molecules21070854openalex-snapshot
Process of Fragment-Based Lead Discovery—A Perspective from NMR
inferred← citeshttps://doi.org/10.3390/molecules23010148openalex-snapshot
Current NMR Techniques for Structure-Based Drug Discovery
inferred← citeshttps://doi.org/10.3390/molecules23081937openalex-snapshot
Probing Protein-Protein Interactions Using Asymmetric Labeling and Carbonyl-Carbon Selective Heteronuclear NMR Spectroscopy
inferred← citeshttps://doi.org/10.3390/molecules25133017openalex-snapshot
Competition NMR for Detection of Hit/Lead Inhibitors of Protein–Protein Interactions
inferred← citeshttps://doi.org/10.3390/molecules25204597openalex-snapshot
NMR as a “Gold Standard” Method in Drug Design and Discovery
inferred← citeshttps://doi.org/10.3390/molecules27113454openalex-snapshot
Biphenyl Ether Analogs Containing Pomalidomide as Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction
inferred← citeshttps://doi.org/10.3390/ph15020137openalex-snapshot
Protein-Protein Interaction Inhibitors Targeting the Eph-Ephrin System with a Focus on Amino Acid Conjugates of Bile Acids
inferred← citeshttps://doi.org/10.3390/polym14142853openalex-snapshot
Biochemical Interactions through Microscopic Techniques: Structural and Molecular Characterization
inferred← citeshttps://doi.org/10.4155/fmc-2018-0312openalex-snapshot
NMR Investigation of Protein–Ligand Interactions for G-Protein Coupled Receptors
inferred← citeshttps://doi.org/10.70675/6952dbaezebb9z4212z9c01z6ea8f2190a06openalex-snapshot
NMR study of 14-3-3 protein-protein interactions and modulation thereof by small molecules
inferred← citeshttps://doi.org/10.70675/af61ef7cz4fe8z4ac9z8eb7z75b5509c33dcopenalex-snapshot
Selective modulation of the Protein Kinase CK2 : discovery, syntheses and characterization of non-ATP site inhibitors of CK2
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.